Low fetal fraction in obese women at first trimester cell-free DNA based prenatal screening is not accompanied by differences in total cell-free DNA

被引:12
作者
Shree, Raj [1 ]
Kolarova, Teodora R. [1 ]
MacKinnon, Hayley J. [1 ]
Hedge, Jaclynne M. [2 ]
Vinopal, Elena [2 ]
Ma, Kimberly K. [1 ]
Lockwood, Christina M. [3 ]
Chandrasekaran, Suchitra [1 ]
机构
[1] Univ Washington, Dept Obstet & Gynecol, Div Maternal Fetal Med, Seattle, WA 98195 USA
[2] Univ Washington, Sch Med, Seattle, WA 98195 USA
[3] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA
关键词
MATERNAL PLASMA; WEIGHT; RISK;
D O I
10.1002/pd.6023
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Objective Reasons for first trimester noninvasive prenatal screening (NIPS) test failure in obese women remain elusive. As dilution from maternal sources may be explanatory, we determined the relationship between obesity, fetal fraction (FF), and total cell-free DNA (cfDNA) using our NIPS platform. Methods We assessed differences in first trimester (<= 14 weeks) FF, indeterminate rate, and total cfDNA between obese (n = 518) and normal-weight women (n = 237) after exclusion of confounders (anticoagulation, autoimmunity, aneuploidy) and controlling for covariates. Results Fetal fraction was lower, and the indeterminate rate higher, in obese compared to controls (9.2% +/- 4.4 vs. 12.5% +/- 4.5, p < 0.001 and 8.4 vs. 1.7%, p < 0.001, respectively), but total cfDNA was not different (92.0 vs. 82.1 pg/mu l, p = 0.10). For each week, the FF remained lower in obese women (all p < 0.01) but did not increase across the first trimester for either group. Obesity increased the likelihood of indeterminate result (OR 6.1, 95% CI 2.5, 14.8; p < 0.001) and maternal body mass index correlated with FF (beta -0.27, 95% CI -0.3, -0.22; p < 0.001), but not with total cfDNA (beta 0.49, 95% CI -0.55, 1.53; p = 0.3). Conclusions First trimester obese women have persistently low FF and higher indeterminate rates, without differences in total cfDNA, suggesting placental-specific mechanisms versus dilution from maternal sources as a potential etiology.
引用
收藏
页码:1277 / 1286
页数:10
相关论文
共 35 条
[1]  
[Anonymous], 2016, Obstet Gynecol, V127, pe123, DOI 10.1097/AOG.0000000000001406
[2]   Sex as a Biological Variable: A 5-Year Progress Report and Call to Action [J].
Arnegard, Matthew E. ;
Whitten, Lori A. ;
Hunter, Chyren ;
Clayton, Janine Austin .
JOURNAL OF WOMENS HEALTH, 2020, 29 (06) :858-864
[3]   Noninvasive prenatal screening at low fetal fraction: comparing whole-genome sequencing and single-nucleotide polymorphism methods [J].
Artieri, Carlo G. ;
Haverty, Carrie ;
Evans, Eric A. ;
Goldberg, James D. ;
Haque, Imran S. ;
Yaron, Yuval ;
Muzzey, Dale .
PRENATAL DIAGNOSIS, 2017, 37 (05) :482-490
[4]   The association between anticoagulation therapy, maternal characteristics, and a failed cfDNA test due to a low fetal fraction [J].
Burns, Whitney ;
Koelper, Nathanael ;
Barberio, Andrea ;
Deagostino-Kelly, Mary ;
Mennuti, Michael ;
Sammel, Mary D. ;
Dugoff, Lorraine .
PRENATAL DIAGNOSIS, 2017, 37 (11) :1125-1129
[5]   The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies [J].
Canick, Jacob A. ;
Palomaki, Glenn E. ;
Kloza, Edward M. ;
Lambert-Messerlian, Geralyn M. ;
Haddow, James E. .
PRENATAL DIAGNOSIS, 2013, 33 (07) :667-674
[6]   Low Fetal Fraction and Birth Weight in Women with Negative First-Trimester Cell-Free DNA Screening [J].
Clapp, Mark A. ;
Berry, Margaret ;
Shook, Lydia L. ;
Roberts, Penelope S. ;
Goldfarb, Ilona T. ;
Bernstein, Sarah N. .
AMERICAN JOURNAL OF PERINATOLOGY, 2020, 37 (01) :86-91
[7]   Autoimmune disorders but not heparin are associated with cell-free fetal DNA test failure [J].
Dabi, Yohann ;
Guterman, Sarah ;
Jani, Jacques C. ;
Letourneau, Alexandra ;
Demain, Adele ;
Kleinfinger, Pascale ;
Lohmann, Laurence ;
Costa, Jean-Marc ;
Benachi, Alexandra .
JOURNAL OF TRANSLATIONAL MEDICINE, 2018, 16
[8]   Low fetal fraction of cell-free DNA predicts placental dysfunction and hypertensive disease in pregnancy [J].
Gerson, Kristin D. ;
Truong, Samantha ;
Haviland, Miriam J. ;
O'Brien, Barbara M. ;
Hacker, Michele R. ;
Spiel, Melissa H. .
PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH, 2019, 16 :148-153
[9]   Analysis of Cell-Free DNA in Maternal Blood in Screening for Aneuploidies: Meta-Analysis [J].
Gil, M. M. ;
Akolekar, R. ;
Quezada, M. S. ;
Bregant, B. ;
Nicolaides, K. H. .
FETAL DIAGNOSIS AND THERAPY, 2014, 35 (03) :156-173
[10]   The influence of low molecular weight heparin medication on plasma DNA in pregnant women [J].
Groemminger, Sebastian ;
Erkan, Sanli ;
Schoeck, Ulrike ;
Stangier, Kerstin ;
Bonnet, Joachim ;
Schloo, Ruediger ;
Schubert, Angela ;
Prott, Eva-Christina ;
Knoll, Ute ;
Stumm, Markus ;
von Kalle, Christof ;
Hofmann, Wera .
PRENATAL DIAGNOSIS, 2015, 35 (11) :1155-1157